Reports and Briefs in Spain

Published within

« | 1 | 2 | 3 | 4 | 5 | » »|

Results are sorted by relevance. Click on heading titles to sort results by different field.

Type Product title / description Pub Price
Report
Report

Product Profiles: Non-Insulin Antidiabetics – Options abound as the SGLT-2 class prepares for market entry

Datamonitor profiles leading, currently marketed non-insulin brands as well as pipeline products launching in the near future. Coverage: the US, Japan, France, Germany, Italy, Spain, and the UK.

Published By Datamonitor
14 Aug 2012 $4800
Buy
Report
Report

Prescribing Influences: Bipolar Disorders - Improved control of bipolar depression persists as greatest unmet need

This report analyzes the unmet needs of bipolar disorders treatment and the attributes of drugs that influence the prescribing decisions made by psychiatrists across the seven major markets.

Published By Datamonitor
30 Jul 2012 $2800
Buy
Report
Report

Product Profiles: Insulin Antidiabetics – Key developers compete for basal insulins market

In-depth analysis of key insulin brands and pipeline agents indicated for the treatment of type 1 and type 2 diabetes. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.

Published By Datamonitor
27 Apr 2012 $4800
Buy
Report
Report

Fee-based Advice in Financial Services: The Consumer Perspective

Across many national markets there is a shift towards the provision of unbiased and transparent financial advice. The introduction of fee-only advice in markets such as the UK will be a change for consumers and may dissuade some from seeking advice.

Published By Datamonitor
05 Apr 2012 $5250
Buy
Report
Report

Product Profiles: Depression – Next generation vies for second-line patients

In-depth analysis of key brands and pipeline agents indicated for the treatment of depression. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.

Published By Datamonitor
17 Jan 2012 $6400
Buy
Brief
Brief

Global Retail Banking Competitor Tracker - November 2011

Datamonitor's Retail Banking Competitor Tracker provides a monthly reference point for the key developments relating to major retail banking players across the globe.

Published By Datamonitor
03 Jan 2012 $2795
Buy
Report
Report

Product Profiles: Insomnia - Orexin receptor antagonists may yet refresh the insomnia market

In-depth analysis of key prescription brands and pipeline agents for the treatment of insomnia. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.

Published By Datamonitor
19 Dec 2011 $6400
Buy
Report
Report

Product Profiles: Osteoporosis - Novel candidates offer the greatest potential

In depth analysis of key brands and pipeline agents indicated for the treatment of osteoporosis. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.

Published By Datamonitor
14 Dec 2011 $6400
Buy
Report
Report

Product Profiles: Psoriasis – Novel therapies raise the bar for biologics

This report analyzes key marketed and pipeline agents for psoriasis, including the current market dynamics of topical, oral and biologic products, key lifecycle management strategies, as well as clinical trial data from 2011 dermatology conferences.

Published By Datamonitor
23 Nov 2011 $6400
Buy
Report
Report

Product Profiles: Prostate Cancer – Recent approvals create competitive environment for new market entrants

Analysis of current market dynamics for the treatment of prostate cancer. The report assesses comparator therapies for prostate cancer, identifies key strategies for drug development, and analyzes commercial and clinical potential of pipeline drugs.

Published By Datamonitor
02 Sep 2011 $6400
Buy

« | 1 | 2 | 3 | 4 | 5 | » »|

No help is available.